Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gonadotropins-IBSA pharmacokinetics in pituitary down-regulated women
NCT06781957Phase 1Completed
- Sponsor
- IBSA Group
- Start
- Sep 2024
- Primary completion
- Jan 2026
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 1, open-label trial of Gonadotropins-IBSA (3 arms), sponsored by IBSA Group. Primary endpoints: Pharmacokinetic endpoints for FSH at 240 hours, Pharmacokinetic endpoints for hCG at 240 hours and 2 more. Started Sep 2024; status: completed.
02
Drugs
Gonadotropins-IBSA
Beyond the preview
Go deeper on NCT06781957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06781957.